Bind Therapeutics management update

Bind Therapeutics Inc. (NASDAQ:BIND), Cambridge, Mass. Business: Cancer, Drug delivery Departed: Jeff Hrkach as chief technology officer, effective the end of November Hired: Hagop Youssoufian as CMO...